NCT00196105View on ClinicalTrials.gov

Malignant Obstruction ZILVER Against Routine Therapy (MOZART I)

NACompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Biliary Tract NeoplasmsPancreatic NeoplasmsJaundice, Obstructive
Interventions
DEVICE

6 mm Nitinol Zilver Stent

DEVICE

10 mm Nitinol Zilver Stent

DEVICE

10 mm Stainless Steel Wallstent

Trial Locations (1)

04102

Maine Medical Center, Portland

All Listed Sponsors
lead

Cook Group Incorporated

INDUSTRY

NCT00196105 - Malignant Obstruction ZILVER Against Routine Therapy (MOZART I) | Biotech Hunter | Biotech Hunter